
zzso The treatment of obesity is based on calorie reduction and moderate physical zzso zzso zzso a zzso zzso zzso zzso is marketed in Europe for the zzso treatment of zzso in combination with a low-calorie diet and physical zzso zzso Four zzso zzso trials involving about zzso patients show that, when combined with a low-calorie diet, zzso 20 zzso leads to an average weight loss of 4 or 5 zzso more than zzso after one year of zzso This is similar to the weight loss reported with zzso zzso zzso zzso on the zzso profile are similar to those reported with zzso zzso zzso has not been shown to reduce morbidity or zzso Patients regain the weight they lost within about 9 months after zzso zzso zzso Three zzso trials have evaluated zzso in smoking zzso The available results (a single conference zzso are zzso In early 2006 the zzso and the European zzso Agency refused to approve zzso for this zzso zzso zzso effects mentioned in published clinical trials of zzso include mental disorders zzso zzso neurological disorders zzso and gastrointestinal disorders zzso zzso No zzso safety data are zzso The possible long-term adverse effects of zzso are zzso zzso In practice, when drug therapy is considered for weight loss, it seems unwise to prescribe zzso this new drug has only limited symptomatic effects and its adverse effects, especially in the long term, are poorly zzso 

